Chronic Bronchitis

Acute bronchitis is one of the most common diagnoses encountered in a primary care setting. It affects millions of individuals resulting in significant impact on health of patients and health care industry. Studies have shown that 90% of times acute bronchitis is caused by a virus, yet health care providers are failing to treat or manage these patients with appropriate therapies (Knutson & Braun, 2002). The focus of this paper is to review the guidelines for treatment of acute bronchitis after differentiating acute bronchitis from other common respiratory disease in terms of epidemiology, pathophysiology, clinical features, diagnosis, differential diagnosis, complications and patient education. Understanding the evaluation and treatment guidelines, nurse practitioners can provide evidence-based practice for patients with acute bronchitis.

Bronchitis is the inflammation of the mucous membranes of the bronchi, the airways that carry airflow from the trachea into the lungs. The thin mucus lining of these airways can become irritated and swollen; the cells that make up the lining may leak fluids in response to the inflammation. Bronchitis most often occurs during the cold and flu season usually coupled with an upper respiratory infection. Bronchitis can be divided into two categories: acute or chronic each of which has distinct etiologies, pathologies, and therapies. I chose this condition because it seemed like an interesting topic to research on, and I am also interested in learning more

A higher level of fats in the body puts the patient at higher risk for Cardiovascular diseases(CAD). The patient's' family has a history of CAD. Her mom and one of her sister have CAD (Lewis et al., 2014, pp. 733-734). The patient states that she has been taking her meds for cholesterol atorvastatin regularly. Her lipase level was 8272 on 11/11/16 and 2829 on 11/12/16 U/L 1069 on 11/13/16 (Ref range 73-393 U/L). Her HDL cholesterol level was 21 ( ref range>49 mg/dl), LDL Cholesterol level 148 ( ref range: <130 mg/dL). Patient statin drug was on hold because it is contradicted on the patient with an elevated level of ALT 80, 61(Ref range 0-50 U/L) and AST 61 on 11/12/16 and 64 on 11/13/16 (ref range 0-45 U/L). The uncontrolled level of could be the cause of concern for stroke or acute myocardial

Her LDL cholesterol level is 190mg/dl this it considered a very high cholesterol level. The optimum LDL level, according the American Heart Association, is less than 100mg/dl.

Good evening Mr. Brown your test results came in and we found out that your Triglycerides are 145 mg/dL, Cholesterol 210 mg/dL, HDL 33 mg/dL, and LDL 160 mg/dL. Normal triglycerides means there are less than 150 milligrams per deciliter (mg/dL) which you do have which is great. A desirable level of cholesterol would be Below 200 mg/dL, and borderline high would be 200-239 mg/dL so because your cholesterol level is 210 mg/dL you are at borderline high. Ideal LDL level for people at very high risk of heart disease would be below 70 and a high level would be 160-189 mg/dL your LDL level is 160 mg/dL therefore it’s high. The best HDL

The Framingham study and others that followed showed us that HDL-cholesterol is an independent cardiovascular risk factor and that the increase of HDL-cholesterol of only 10 mg/dL leads to a risk reduction of 2-3% (PubMed.gov, Nov. 2012). Higher levels of HDL cholesterol result in a risk of cardiovascular disease closer to the default risk. Cardiovascular disease risk increases then plateaus with greater ratios between total cholesterol and HDL cholesterol. Thus, higher levels of HDL cholesterol proportionate to levels of total cholesterol relate to lower cardiovascular disease risk (Lecture #3). Having a HDL-cholesterol of 60 mg/dL and above is the best place for a person to be. A bit lower, but considered a good HDL-cholesterol level standing is 40-49 mg/dL for men and 50-59 mg/dL for women. All three of us, me, my mother, and the case study Danny are in good standing regarding HDL-cholesterol levels, my mother with 55 mg/dL, me with 50 mg/dL, and Danny with 40

Have you ever known a person who smokes and has a hard time doing every day activities, due to difficulty of breath, or constantly coughing. He or she may have Chronic Obstructive Pulmonary Disease, or COPD. COPD is a progressive and treatable lung disease that causes shortness of breath due to obstruction of air way (COPD, 2013). Progressive means that is gradually gets worse over time. It is a combination of chronic bronchitis and emphysema (Causes,2014). Chronic bronchitis is inflammation of the bronchioles, which causes mucus build up (Davis,2016). Emphysema is when the air sacs get enlarged (Smoking, 2016). Since the disease does not have a cure yet it is important to know pathology (path of disease), epidemiology (who is effected in a population), ethology (who is effected genetically), manifestation (symptoms), treatment, and outcome.

What clinical findings correlate with M.K.’s chronic bronchitis? What type of treatment and recommendations would be appropriate for M.K.’s chronic bronchitis?

COPD is a disease that depletes a person of air. This disease is the fourth top cause of death in the United States. COPD describes several lung diseases including emphysema, chronic bronchitis, refractory asthma, and other forms of bronchiectasis. There is no average case, as every case is different from the next. This disease is long term but treatable.

A routine cholesterol screening involves a simple blood test. An LDL number of 190 mg/dL is considered high, but an HDL level below 40 mg/dL is too low and is a risk for heart disease. The levels of both HDL and LDL are added together for a total cholesterol number. The risk breakdown for the levels are;

Martina, your overall cholesterol measurement of 172 mg/dL is below the recommend upper limit of 200 [1]. Additionally, your HDL (high-density lipoprotein)-cholesterol measurement of fifty-six mg/dL is also within the normal limits, which are defined as a reading greater than 40 but less than or equal to 60 mg/dL [1]. Your LDL (low-density lipoprotein)-cholesterol reading is extremely close to being below the recommended limit of 100 mg/dL: your reading was 101 mg/dL [1]. The recommended levels are the values at which your risk for several diseases is minimized. Your triglyceride reading of 78 mg/dL was well within the normal limit of less than 150 mg/dL, but your glucose reading was indicative of prediabetes.

The World Health Organization (WHO) (2006A) defines COPD as a disease state characterized by airflow limitation that is not wholly reversible. The airflow limitation is usually both progressive and associated with abnormal inflammatory response of the lungs to noxious particles or gases. John's chronic bronchitis is defined, clinically, as the presence of a chronic productive cough for 3 months in each of 2 successive years, provided other causes of chronic cough have been ruled out. (Mannino, 2003). The British lung Foundation (BLF) (2005) announces that chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes which is the explanation for John's dyspnea. The BLF (2005) believe that when the bronchi become inflamed less air is able to flow to and from the lungs and once the bronchial tubes have been irritated over a long period of time, excessive mucus is produced. This increased sputum results from an increase in the size and number of goblet cells (Jeffery, 2001) resulting in John's excessive mucus production. The lining of the bronchial tubes becomes thickened and an irritating cough develops, (Waugh & Grant 2004) which is an additional symptoms that john is experiencing.

Bronchiolitis is defined by the textbook as, “a diffuse, inflammatory obstruction in the small airways or bronchioles occurring most commonly in children” (Heuther & McCance, 2012). It is an acute inflammatory disease of the lower respiratory tract that occurs most commonly in infants and is caused by infection with seasonal viruses such as respiratory synctial virus (RSV) (Zorc & Hall, 2010). Bronchiolitis often results from an obstruction of the small airways. It is the leading cause of infant hospitalization in the United States (Zorc & Hall 2010) and is arguably the most common significant medical illness of childhood, with at least “1 in 7 normal infants developing symptomatic bronchiolitis in his or her first year of

Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.

Studies have shown that people with hypertension were able to lower their blood pressure by consuming diets high in Omega-3 fatty acids or taking fish oil supplements. After analyzing the results of 17 clinical studies using fish oil supplements, researchers determined that taking 3 or more grams of fish oil per day may lower blood pressure in people with untreated hypertension.